Boothbay Fund Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Buy
230,684
+102,822
+80% +$1.11M 0.05% 471
2026
Q1
$1.08M Buy
127,862
+54,785
+75% +$599K 0.01% 903
2025
Q4
$825K Buy
+73,077
New +$905K 0.01% 880
2023
Q4
– Sell
-22,244
Closed -$579K – 1660
2023
Q3
$579K Sell
22,244
-58,039
-72% -$1.21M 0.01% 971
2023
Q2
$1.92M Buy
80,283
+7,173
+10% +$123K 0.04% 583
2023
Q1
$999K Sell
73,110
-77,807
-52% -$1.24M 0.02% 983
2022
Q4
$2.09M Buy
+150,917
New +$2.13M 0.05% 581

Other funds holding BHVN

Boothbay Fund Management's BHVN Position: Q2 2026 in Review

Boothbay Fund Management increased its Biohaven (BHVN) stake by 80% in Q2 2026, buying an estimated $1.11M and bringing the position to 230,684 shares worth $3.43M. The position accounts for 0.05% of the portfolio, ranked #471.

Boothbay Fund Management first reported a position in BHVN in Q4 2022 and has held it in 7 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Boothbay Fund Management held 230,684 shares of Biohaven worth $3.43M as of Q2 2026.
  • Boothbay Fund Management bought 102,822 Biohaven shares in Q2 2026, an estimated $1.11M.
  • Biohaven made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #471 holding.
  • Boothbay Fund Management first reported a position in Biohaven in Q4 2022 and has held it in 7 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.